Ditchcarbon
  • Contact
  1. Organizations
  2. HemaCare Corporation
Public Profile
Health Services
US
updated 8 months ago

HemaCare Corporation Sustainability Profile

Company website

HemaCare Corporation, a leading provider in the biotechnology sector, is headquartered in the United States and operates extensively across North America. Founded in 1978, HemaCare has established itself as a pivotal player in the field of human cellular products, specialising in the collection, processing, and distribution of blood components and cellular therapies. The company’s core offerings include a range of high-quality leukapheresis products and customised cell processing services, which are distinguished by their commitment to quality and regulatory compliance. HemaCare's innovative approach has positioned it as a trusted partner for research institutions and pharmaceutical companies, contributing significantly to advancements in regenerative medicine and immunotherapy. With a strong market presence and a reputation for excellence, HemaCare continues to drive progress in the biotechnology landscape.

DitchCarbon Score

How does HemaCare Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

57

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

21

Industry Benchmark

HemaCare Corporation's score of 57 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.

77%

Let us know if this data was useful to you

HemaCare Corporation's reported carbon emissions

Inherited from Charles River Laboratories International, Inc.

HemaCare Corporation, headquartered in the US, currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of Charles River Laboratories International, Inc., which means that any emissions data or climate commitments may be inherited from this parent organisation. As part of its corporate family relationship, HemaCare Corporation aligns with the sustainability initiatives and targets set by Charles River Laboratories. This includes participation in various climate-related initiatives such as the Science Based Targets initiative (SBTi), CDP, and RE100, all of which are cascaded from Charles River Laboratories. However, specific reduction targets or achievements for HemaCare Corporation itself have not been disclosed. In summary, while HemaCare Corporation is committed to climate action through its association with Charles River Laboratories, detailed emissions data and specific reduction targets for HemaCare are currently unavailable.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

201820192020202120222023
Scope 1
86,284,000
-
00,000,000
00,000,000
00,000,000
00,000,000
Scope 2
79,271,000
-
00,000,000
00,000,000
00,000,000
00,000,000
Scope 3
-
000,000,000
-
000,000,000
000,000,000
000,000,000

How Carbon Intensive is HemaCare Corporation's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. HemaCare Corporation's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

How Carbon Intensive is HemaCare Corporation's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for HemaCare Corporation is in US, which has a low grid carbon intensity relative to other regions.

HemaCare Corporation's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

HemaCare Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251030.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy